Click on the subcategory below to find drug monographs for that particular area.
Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Download or print easy-to-read disease leaflets for your patients.
Get valuable insight on select drug products and medically-relevant topics, courtesy of the pharmaceutical industry.
Salix announced the outcome and completion of two Phase 3 studies which evaluated the efficacy and safety of budesonide foam in the treatment of active mild to moderate ulcerative proctitis or ulcerative proctosigmoiditis.
Diclegis (doxylamine succinate and pyridoxine HCl; Duchesnay USA) delayed-release tablets are now available across the country.
Obese and overweight adults can improve symptoms of gastroesophageal reflux disease by losing weight, while regaining even small amounts of weight can worsen symptoms.
For patients with stable Crohn's disease, vitamin D supplementation is associated with improvements in hand-grip strength, fatigue, and quality of life.
The FDA has approved Simponi (golimumab for subcutaneous injection; Janssen Biotech) to induce and maintain clinical response in adults with ulcerative colitis.
